REQUEST A DEMO
Total
USD $0.00
Search more companies

Oncotransfer Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Information Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Advertising, Public Relations, and Related Services | Convention and Trade Show Organizers | Educational Services | Exam Preparation and Tutoring | All Other Miscellaneous Schools and Instruction | Health Care and Social Assistance
Full name: Oncotransfer Sp. z o.o. Profile Updated: November 15, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Oncotransfer Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on February 06, 2019. From the latest financial highlights, Oncotransfer Sp. z o.o. reported a net sales revenue increase of 44.91% in 2024. Its’ total assets recorded a growth of 109.42%.

Headquarters
Ul. Wilhelma Konrada Roentgena 5
Warsaw; Mazowieckie; Postal Code: 02-781

Contact Details: Purchase the Oncotransfer Sp. z o.o. report to view the information.

Website: http://oncotransfer.pib-nio.pl

Basic Information
Registered Capital:
Purchase the Oncotransfer Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Oncotransfer Sp. z o.o. report to view the information.
Incorporation Date:
February 06, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Oncotransfer Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
44.91%
Total operating revenue
45.01%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
109.42%
Total Equity
274.31%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?